Navigation Links
012 Smile.Communications Reports Financial Results for Q4 and Full Year 2007
Date:2/26/2008

3.846

Year ended

Year ended December 31 December 31

2007 2006 2005 2007

(Unaudited) (Audited) (Audited) (Unaudited)

NIS thousands $ thousands

Revenues 1,102,888 343,086 244,376 286,762

Costs and expenses

Cost of revenues 760,705 224,565 136,856 197,791

Selling and marketing

expenses 157,304 59,864 60,595 40,901

General and administrative

expenses 57,984 22,921 22,859 15,076

Impairment and other

charges 10,433 10,187 - 2,713

Total costs and expenses 986,426 317,537 220,310 256,481

Income from operations 116,462 25,549 24,066 30,281

Financial expenses, net 52,043 17,266 5,342 13,532

Income before tax expenses 64,419 8,283 18,724 16,749

Tax expenses 23,462 10,315 6,972 6,100

Net income 40,957 (2,032) 11,752 10,649

Income (loss) per share

Basic and diluted earnings

per share (in NIS) 2.1 (0.11) 0.64 0.55

Weighted average number

of ordinary shares used

in calculation of basic

and diluted earnings

per share 19,493,329 18,370,000 18,370,000 19,493,329

012 Smile.Communications Ltd.

Reconciliation Table of Non-GAAP Measures

Year ended Dec
'/>"/>

SOURCE 012 Smile.communications Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. 012 Smile.Communications to Deploy Extensive WiFi Internet Access System for Sheba Medical Center
2. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
3. Haemacure Reports Third Quarter 2007 Results
4. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
5. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
6. MDS Reports Third Quarter 2007 Results
7. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
8. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
9. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
10. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
11. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ISCO,Nov.25/PRNewswire/--TheBayAreaAirQualityManag...pare the Air Alert forThursday,November...anyothersolidfuel,bothindoorsandoutdoors. ,, "C...ytomorrow,"saidJackBroadbent,executiveofficerofthe...hehealthoftheirneighborsandfellowcommunitymemberst...
(Date:11/25/2009)...ivors of testicular cancer who were treated with c...ffects, including neurological side effects and Ra...d with chemotherapy, according to a new study publ...tional Cancer Institute . , Marianne Brydy, M.D....ity Hospital, in Bergen, Norway, and colleagues co...
(Date:11/25/2009)... discovery that grew out of a collaboration betwee...offer hope to the nearly 10 million Americans who ...lso known as hardening of the arteries, peripheral... problem in which narrowed arteries reduce blood f...d flag for vascular disease, heart attack and stro...
(Date:11/25/2009)...-up period was too short to draw definite conclusi...5 (HealthDay News) -- In diabetic patients with bl...fference in outcomes at one year whether patients ...g, British researchers report. , Bypass surgery...ents with coronary artery disease. However, less i...
(Date:11/25/2009)... Evaluation and treatment clinics to resu...stock (Vocus) November 25, 2009 -- Centegra Health... and H1N1 vaccine shots at four Centegra Primary C...nt of vaccine has arrived. The clinics are at CPC ...nry and will be open as follows: ,   F...
Breaking Medicine News(10 mins):Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
... BARCELONA, SPAIN, September 25, 2007 In clinica...lung cancer (NSCLC) that are classified as having ...nificant higher survival when treated in the secon...t # 6521) were presented at the 14th European Can...
...tient received stolen piece of bone during neck su...exas man has filed a,lawsuit against the billion-d...YSE: MDT ) for fraud and negligence in a "body-sn...eme Court of the State of New York also names as d...
...W YORK, Sept. 26 The American Liver Foundation (A...search and improving the,quality of life for the 3...today that Rick Smith has been named to become the...ience leading prominent,national health organizati...
... Barcelona, Spain: In a surprising finding, Americ...ageal cancer, married patients dont fare as well a...their quality of life. , In the study, presented..., a non-cancerous condition linked to acid reflux,...
...USTON, Sept. 26 US Med-Equip, an industry leader ...rvice and smarts to acute,care and homecare provid...Houston, Texas. This expansion into a state of the...on it for future,plans. The 15,000 square feet of ...
...S ANGELES, Sept. 26 TIGroup, Inc. (OTC,Bulletin B...s provider to,the healthcare industry focused on a...sses designed to deliver quality healthcare servic...company,s board,since 2001. Smith was most recent...
Other Medicine News:Health News:Studies suggest key correlation between lung cancer subtype and treatment outcomes 2Health News:Studies suggest key correlation between lung cancer subtype and treatment outcomes 3Health News:The Law Offices of John David Hart: Texas Man Sues Medtronic in 'Body-Snatching' Case 2Health News:The American Liver Foundation Appoints Rick Smith, a Twenty-Year Veteran of The MS Society, as Chief Executive Officer 2Health News:Married esophageal cancer patients fare worse in some quality of life aspects than single patients 2Health News:US Med-Equip Expands Corporate Support Center 2Health News:TIGroup Names Dennis M. Smith as Chief Financial Officer 2Health News:TIGroup Names Dennis M. Smith as Chief Financial Officer 3Health News:TIGroup Names Dennis M. Smith as Chief Financial Officer 4
(Date:11/25/2009)..., EXTON,Pa.,Nov.25/PRNewswire/--BioTrendsResear...: Stelara report,thefirstinamulti-phasesyndicate...rtho-Biotech,sStelara,fromproductlaunchthroughthef...videsquantitativeinformationfrom75uniqueDermatolog...portsassesstrialanduseofStelara,obstaclestouse,typ...
(Date:11/25/2009)..., WESTPALMBEACH,Fla.,Nov.25/PRNewswire-FirstCal...,especiallythe27millionlivingwithuntreated hearing...istCindyBeyer. ,, Dr.Beyer,seniorvicepresidento...areand hearingaids companies,saidstudieshavelinked...,"whichcaneasilybeintensifiedatholidaygatheringswi...
(Date:11/25/2009)..., RANCHOCORDOVA,Calif.,Nov.25/PRNewswire/--AMPA...cCorporation(Nasdaq: APFC )announcedtodaythatitrec...tyAwardattheAnnualStatewideEnvironmentalSummit,spo...ociation(CMTA),theIndustrialEnvironmentalAssociati...ICC)heldinSanDiego.Thisisthemostprestigiousawardav...
Breaking Medicine Technology:Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2Baking Soda May Be Key Ingredient for Kidney Patients 52007 1Baking Soda May Be Key Ingredient for Kidney Patients 52007 2Omar S Manejwala MD Speaks Out Nationally on Diprivan Propofol Abuse 52002 1Omar S Manejwala MD Speaks Out Nationally on Diprivan Propofol Abuse 52002 2Omar S Manejwala MD Speaks Out Nationally on Diprivan Propofol Abuse 52002 3Omar S Manejwala MD Speaks Out Nationally on Diprivan Propofol Abuse 52002 4Wake Forest Baptist Medical Center Names Chadwick CFO 51998 1Wake Forest Baptist Medical Center Names Chadwick CFO 51998 2
...DA Submission in 2009, SEATTLE, March 25 Cell Th...nced today that enrollment is complete in,the phas... (BBR2278) for,patients with relapsed diffuse larg... of the data is expected in the second half of 200...nd Drug Administration (FDA) the data,could provid...
...if., March 24 NuRx,Pharmaceuticals, Inc. (OTC Bul...e first patient in a Phase I clinical trial of the...X4204., The single-center study, which NuRx expec... is designed to evaluate the safety and tolerabili... drug candidate in clinical,trials., "Our preclin...
Other Medicine Technology:Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL 2Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL 3Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL 4NuRx Pharmaceuticals Doses First Patient in Phase I Clinical Trial of First-in-Class RXR Agonist NRX4204 2
Schuco® 3000 Nebulizer
... developing diverse medical products for more than...ed an outstanding reputation for innovation, quali...ationally recognized brands include the Labtron&re...ical sundry products, Bristoline® microscopes,...
...ntrainment Nebulizers deliver particulate humidity...tion patients. For your convenience, Thera-Mist&re...y of sterile water., ,The P30000N, for normal flo...tal flow range of 68-24 lpm. For your high flow ne...
...er can be held at angles up to 45° without sac...mn, finger grooves for a non-slip gripping surface... of regular oxygen tubing. The large diffuser and...tain optimum mist concentration at every setting. ...
Medicine Products: